Atticus Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-488
Closed -$44.4K 280
2025
Q2
$44.4K Buy
488
+298
+157% +$27.2K 0.01% 325
2025
Q1
$17.8K Hold
190
0.01% 330
2024
Q4
$17.3K Hold
190
0.01% 341
2024
Q3
$19.7K Sell
190
-6
-3% -$612 0.01% 332
2024
Q2
$19K Hold
196
0.01% 316
2024
Q1
$17.6K Hold
196
0.01% 338
2023
Q4
$15.6K Hold
196
0.01% 353
2023
Q3
$13.9K Hold
196
0.01% 370
2023
Q2
$15.1K Hold
196
0.01% 363
2023
Q1
$14.7K Hold
196
0.01% 349
2022
Q4
$15.4K Sell
196
-40
-17% -$3K 0.01% 358
2022
Q3
$19K Hold
236
0.01% 316
2022
Q2
$19K Hold
236
0.01% 345
2022
Q1
$18K Buy
236
+40
+20% +$3.17K 0.01% 346
2021
Q4
$17K Buy
+196
New +$15.3K 0.01% 318

Other funds holding CL

Atticus Wealth Management's CL Position: Q3 2025 in Review

Atticus Wealth Management sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 488 shares — an estimated $44.4K sold.

Atticus Wealth Management first reported a position in CL in Q4 2021 and held it in 15 quarters. The position peaked at $44.4K in Q2 2025. 1,846 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Atticus Wealth Management reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 488 Colgate-Palmolive shares in Q3 2025, an estimated $44.4K.
  • Atticus Wealth Management first reported a position in Colgate-Palmolive in Q4 2021 and held it in 15 quarters.
  • Atticus Wealth Management's Colgate-Palmolive position peaked at $44.4K in Q2 2025.
  • 1,846 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.